Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder

Urology

Volumn 59, Issue 2, 2002, Pages 308-312

  Staack, Andrea ^a   Koenig, Frank ^a   Daniltchenko, Dmitri ^a   Hauptmann, Steffen ^a   Loening, Stefan A ^a   Schnorr, Dietmar ^a   Jung, Klaus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC VALUE; ENZYME ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

ANALYSIS OF VARIANCE; CARCINOMA, TRANSITIONAL CELL; CATHEPSIN B; CATHEPSINS; CREATININE; CYSTEINE ENDOPEPTIDASES; HUMANS; NEOPLASM PROTEINS; PILOT PROJECTS; URINARY BLADDER NEOPLASMS;

EID: 0036170990     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01517-5     Document Type: Article

References (29)

1. Mammalian cysteine protease inhibitors; biochemical properties and possible roles in tumor progression
2. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues
3. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins
4. Cystatins in health and disease
5. Proteinase activity in invasive cancer of the breast; correlation with tumor progression
6. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival
7. Prognostic value of increased lung tumor tissue cathepsin B
8. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue
9. Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma; no evidence for dysregulated proteolytic balance
10. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia
11. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma
12. Mechanisms of human bladder tumor invasion; role of protease cathepsin B
13. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s)
14. A study on cathepsin B-like substance in cancer of the urinary tract
15. Enzyme activities in urine; how should we express their excretion? A critical literature review
16. Cancer statistics, 2000
17. Cathepsin B in the growth of colorectal cancer; suppressive effect of leupeptin on the growth of DMH-induced rat colon neoplasm
18. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease
19. Cathepsin B in tumors, normal tissue and isolated cells from the human lung
20. Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands
21. Role for cathepsin B and cystatins in tumor growth and progression
22. Expression of cysteine protease inhibitors in human gliomas and meningiomas
23. Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis
24. Cathepsin B in angiogenesis of human prostate; an immunohistochemical and immunoelectron microscopic analysis
25. Tissue cathepsins as tumor markers
26. Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis
27. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma; a comparison with clinically used tumor markers
28. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma
29. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas